Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Dilution |
0.1-0.5μg/ml |
0.5-1μg/ml |
Not tested in other applications.
Calculated MW
Product Note
Superfamily members of ARID2 are not reactive to this antibody.
Form
Liquid
Buffer
4mg Trehalose, 0.9mg NaCl, 0.2mg Na₂HPO₄
Preservative
0.05mg Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
0.5 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
A synthetic peptide corresponding to a sequence of human ARID2 (DERRKGLAFLDELRQFHHSR).
Purification
Purified by antigen-affinity chromatography
Conjugation
Unconjugated
Note
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Synonyms
AT-rich interaction domain 2 , ARID2 , ATrich interaction domain 2 , BAF200 , p200
Cellular Localization
Nucleus
Background
This gene encodes a member of the AT-rich interactive domain (ARID)-containing family of DNA-binding proteins. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and chromatin structure modification. This protein functions as a subunit of the polybromo- and BRG1-associated factor or PBAF (SWI/SNF-B) chromatin remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors. Mutations in this gene are associated with hepatocellular carcinomas. A pseudogene of this gene is found on chromosome1. [provided by RefSeq, Dec 2016]
Database
Research Area